Gaboxadol is a research compound that acts as an agonist at GABAA receptors. It was investigated for potential applications in sleep disorders and has been studied for conditions such as Angelman syndrome, but it was never marketed.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Gaboxadol?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(RS)-pentobarbital
pharmaceutical raw material
Chlorprothixene hydrochloride
pharmaceutical raw material
1',4-Dihydroxy Midazolam
pharmaceutical raw material
Lanthanum carbonate octahydrate
pharmaceutical raw material
Butoconazole nitrate
pharmaceutical raw material
The international HS code for Gaboxadol (CAS 64603-91-4) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one
ZXRVKCBLGJOCEE-UHFFFAOYSA-N
C1CNCC2=C1C(=O)NO2
Sourcing Gaboxadol?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.